A new two-pill combo is changing the game for women with a rare, stubborn form of ovarian cancer—thanks in part to research at Cleveland Clinic and OSU Wexner. Instead of relying on old treatments that barely worked, this new approach actually slows tumor growth and blocks cancer cells from dodging therapy. For many patients, this means hope where there was none. It’s wild to think that, until now, these women had no targeted options. What do you think this means for the future of rare cancer treatments? #Health #BodyHealth #ClevelandClinic